secwatch.observer — SEC 8-K summary
======================================

Issuer:     NGM BIOPHARMACEUTICALS INC (—)
CIK:        0001426332
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0001193125-23-288513
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NGM Biopharmaceuticals receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days
--------------------------------------------------------------------------------

- Received Nasdaq notice on Dec 1, 2023; bid price below $1.00 for 30 consecutive business days.
- Has until May 29, 2024 (180 days) to regain compliance by closing at $1.00+ for 10 consecutive days.
- May transfer to Nasdaq Capital Market for an additional 180-day compliance period if needed.
- Company will monitor and consider options, including a potential reverse stock split, to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426332/000119312523288513/0001193125-23-288513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426332/000119312523288513/d618000d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-288513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer